Vantage logo

The ipatasertib curate’s egg

Roche’s Akt inhibitor’s first pivotal result, in first-line prostate cancer, is at best a partial success and at worst an irrelevance.

Vantage logo

Soleno slims down

The group’s diazoxide choline becomes the latest biotech project to fail in Prader-Willi syndrome.